PetaSight, an AI-led operating system for life sciences primary market research, has acquired Babbage Insight Two, a company specializing in patent-pending algorithms for generating business insights and validating signals. The deal is aimed at advancing PetaSight’s platform into a more comprehensive, intelligence-driven system for pharmaceutical research teams, though financial terms were not disclosed.
The acquisition positions PetaSight to address longstanding inefficiencies in the roughly $6 billion life sciences primary market research sector, where workflows are often fragmented across disconnected tools and manual processes. By integrating Babbage Insight’s technology, PetaSight is building a unified software environment that enables organizations to move from raw data to decision-ready intelligence with improved transparency, auditability, and rigor.
The combined platform introduces automated orchestration capabilities, coordinating stakeholders through agentic workflows that handle repetitive tasks while preserving human oversight for strategic decisions. It also incorporates deterministic validation methods that test, prioritize, and explain data signals, helping improve confidence in research outputs.
PetaSight said the integration will initially focus on enhancing signal identification and data quality control, with a broader roadmap to create a fully unified operating system where data orchestration, validation, and synthesis operate seamlessly.
The move reflects PetaSight’s broader strategy to replace fragmented research delivery models with a centralized, auditable, and intelligence-led system for global life sciences teams.
KEY QUOTES:
“This vital sector still runs on fragmented tools and manual oversight. By integrating Babbage’s technology, we are adding a sophisticated intelligence layer to our governance platform, positioning PetaSight as the essential software ecosystem for global organizations requiring speed and uncompromised rigor.”
Sandeep Sankhla, CEO of PetaSight
“Trust in data is fundamentally a software problem, not just a sampling problem. Researchers discard roughly 38 percent of survey data due to quality concerns. PetaSight brings the governed workflow and evidence trails; Babbage adds a deterministic validation layer designed to test and explain signals. Together, this creates a stronger operating model for life sciences PMR.”
Manu Bhardwaj, COO of Babbage Insight
